Latest filing published 24 Apr 2026 for Organogenesis Holdings Inc., €1,154.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Brian Grow is a declared insider of Organogenesis Holdings Inc. (senior executive), with filings sourced from SEC (Form 4). The record holds 36 filings, for trades running from 10 December 2018 to 18 February 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 24 April 2026 with an option exercise (€1,154) in Organogenesis Holdings Inc. Typically, a trade is published a median of 3 days after it takes place. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
16 of 16 declarations